Regulating TAM iron metabolism within the TIME, specifically by promoting iron uptake and storage in M2-type macrophages while inhibiting iron release, allows iron accumulation in TAMs to enhance ROS production, increase p300/CBP acetyltransferase activity, and promote p53 acetylation
The ADA highlights the benefits of combining GLP-1 receptor agonists with SGLT2 inhibitors, stating: Combined use [of GLP-1 RAs and SGLT2 inhibitors] may be considered for additive cardio-kidney protection
Rather than airlines redesigning cabins or adjusting policies, analysts say a gradual shift in average passenger weight could be happening outside the industry altogether
The goal is not necessarily no medication. The goal is the least medication necessary for safety and function, supported by the strongest biochemical foundation possible
SPECIAL REPORT The Basics of GLP-1 Menu Innovation Understanding the flavor cravings of GLP-1 Guests This article is part of a two-part series exploring GLP-1s and their potential impact on foodservice
